FFAR2-/- mice fed a high fat diet displayed reduced beta-cell mass and in vitro treatment of isolated human islets with a specific agonist of FFAR2 increased insulin secretion, making FFAR2 a potential therapeutic target for T2DM [85]. This evidence concerns the gene FFAR2 and type 2 diabetes mellitus.